MARKET

HROWM

Harrow Health Inc
HROWM
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-53.0899
4.645
19.25
-
Harrow says QUELL trial of IHEEZO posts topline data in Q4 2026
PUBT · 2d ago
SAMSUNG BIOEPIS RELAUNCHES BYOOVIZ® (RANIBIZUMAB-NUNA) IN THE UNITED STATES IN PARTNERSHIP WITH HARROW
Reuters · 07/01 11:02
Harrow holds annual shareholder meeting, elects four directors
PUBT · 06/22 11:31
HARROW RE-LAUNCHES VERKAZIA® (CYCLOSPORINE OPHTHALMIC EMULSION) 0.1% FOR VERNAL KERATOCONJUNCTIVITIS, ADDRESSING SIGNIFICANT UNMET NEED IN PEDIATRIC EYECARE
Reuters · 06/10 11:01
Harrow to present at William Blair Growth Stock Conference
PUBT · 05/27 11:00
Harrow director Adrienne Graves acquires 1,000 common shares for $31,070
PUBT · 05/19 11:01
Harrow CEO Mark Baum buys 10,000 common shares for $302,000
PUBT · 05/15 11:02
Harrow President, CFO Andrew Boll buys 3,500 shares worth $104,650
PUBT · 05/15 11:01
More

Webull offers Harrow Health Inc stock information, including NASDAQ: HROWM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROWM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HROWM stock methods without spending real money on the virtual paper trading platform.